Community Health Workers in clinical research at the example of a phase IIIb/ IV antimalarial drug trial conducted in five African countries

Malaria is a parasitic disease transmitted by infected Anopheles mosquitoes. Despite the over a century long history of control and elimination efforts, malaria still represents an important disease burden, particularly for sub-Saharan Africa.[1] New tools and interventions like insecticide treated bed nets or the introduction of artemisinin-based combination therapies have contributed importantly to the progress towards malaria elimination and eradication since the beginning of the millennium. Notwithstanding, this progress has stalled since 2015 and the 2020 milestones of the “Global Technical Strategy For Malaria” set forth by WHO could not be reached.[2] While elimination could be accomplished in several countries with low endemicity, absolute case numbers have further increased in the 10 highest burden countries in Africa.[3]
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Tags: Perspective Source Type: research